• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

COX:FP

2.4450 EUR 0.1760 7.76%

As of 11:36:50 ET on 04/17/2014.

Snapshot for NicOx SA (COX)

Open: 2.2720 Day's Range: 2.2700 - 2.5130 Volume: 1,418,390
Previous Close: 2.2690 52wk Range: 2.2600 - 3.0300 1-Yr Rtn: +2.30%

Stock Chart for COX

No chart data available.
  • COX:FP 2.4450
  • 1D
  • 1M
  • 1Y
2.2690
Interactive COX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for COX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.2651
Est. EPS (EUR) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 181.70
Shares Outstanding (M) 74.32
30 Day Average Volume 489,624
Price/Book (mrq) 2.8775
Price/Sale (ttm) 596.2131
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date 05/30/1999
5 Year Dividend Growth -
Next Earnings Announcement 05/16/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for COX

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for COX

NicOx develops pharmaceuticals using recently discovered properties of nitric oxide. The Company develops drugs-candidates for the potential treatment of inflammatory, cardiometabolic and ophthalmological diseases. NicOx's lead compound naproxcinod is developed for the relief of the signs and symptoms of osteoarthritis.

Michele GarufiChairman/CEO/Co-FounderEvelyne NguyenChief Financial Officer
Gavin SpencerExec VP:Corporate DevelopmentPhilippe MasquidaExec VP/Mng Dir:European & Intl Ops
More Company Profile & Key Executives for COX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil